Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.

KMS MEDISURGI LIMITED ® Plot No-297/301 May Building, Gr. Floor Marine lines (EAST), Princess Street, Mumbai 400 002 Maharashtra (India) o CIN: L51397MH1999PLC119118 Website: www.kmsgroup.in | E-mail Id: cskms99@gmail,com Tel: 022-66107700/22, 022-67498822 | Fax: +91-22-22061111 Date: 13.10.2026 BSE limited Phiroze Jeejeebhoy towers, Dalal Street, Mumbai 400001 Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 30" September, 2026. Ref: KMS Medisurgi limited (scrip code- 540468) Dear Sir, Pursuant to Regulations 74(5) of SEBI (Depositories and Participants) Regulations, 2018, please find enclosed herewith certificate received from KFIN Technologies Limited, Registrar & Share Transfer Agent of the company for the quarter ended 30™ September 2026. You are requested to take note of the same. Yours Faithfully, For KMS MEDISURGI LIMITED Siddharth Kanakia Managing Director DIN: 07595098 Place: Mumbai KFIN/KML/74(5) Date: 13.10.2026 COMPANY SECRETARY KMS MEDISURGI LIMITED 297/301, MAY BUILDING GR. FLOOR MARINE LINE EAST MUMBAI 40002 Dear Sir(s), With reference to the captioned regulation, we hereby confirm that the said Regulation is not applicable to the Company, as the entire holding of the Company’s shares are in demat form, and we have not received any request from any members of the Company for re-materialisation during the quarter ended on 30th September, 2026. Request to kindly take the above on record. Thanking you, Yours faithfully, KFIN TECHNOLOGIES LIMITED Dnyanesh Gharote Vice President CIN: L72400TG2017PLC117649